Loading...
Docoh

InMed Pharmaceuticals (INM)

InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol ('CBN'), in diseases with high unmet medical need. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs.

INM stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

28 Sep 22
1 Oct 22
30 Jun 23
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Jun 22 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 6.18M 6.18M 6.18M 6.18M 6.18M 6.18M
Cash burn (monthly) (no burn) 98.86K 2.62M 1.55M 1.35M 1.3M
Cash used (since last report) n/a 301.1K 7.99M 4.72M 4.11M 3.96M
Cash remaining n/a 5.88M -1.81M 1.46M 2.07M 2.22M
Runway (months of cash) n/a 59.4 -0.7 0.9 1.5 1.7

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
10 Aug 22 Nicole Lemerond Employee Stock Option Common shares Grant Acquire A No No 0.39 14,000 5.46K 14,000
2 Jun 22 Alexandra Diane Janet Mancini Employee Stock Option (Expiration) Common shares Dispose H No No 11.75 1,515 17.8K 98,787
2 Jun 22 Eric A Adams Employee Stock Option (Expiration) Common shares Dispose H No No 11.75 13,636 160.22K 337,576
17 May 22 Baldasare Bryan T Employee Stock Option Common Shares Grant Dispose A No No 0.8 14,000 11.2K 14,000
13F holders Current Prev Q Change
Total holders 16 16
Opened positions 3 6 -50.0%
Closed positions 3 3
Increased positions 1 1
Reduced positions 2 1 +100.0%
13F shares Current Prev Q Change
Total value 513K 326K +57.4%
Total shares 1.09M 346.42K +215.9%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Armistice Capital 956.12K $450K NEW
Renaissance Technologies 49.7K $23K +10.0%
Two Sigma Advisers 48.28K $23K -68.8%
Geode Capital Management 13.91K $6K 0.0%
Citadel Advisors 12.97K $6K NEW
Creative Planning 10.83K $5K 0.0%
Advisor 1.19K $0 0.0%
AllSquare Wealth Management 545 $0 0.0%
RY Royal Bank Of Canada 250 $0 0.0%
NA National Bank of Canada 196 $0 -43.5%
Largest transactions Shares Bought/sold Change
Armistice Capital 956.12K +956.12K NEW
Two Sigma Advisers 48.28K -106.22K -68.8%
Empery Asset Management 0 -61.74K EXIT
Two Sigma Investments 0 -39.7K EXIT
Two Sigma Securities 0 -17.98K EXIT
Citadel Advisors 12.97K +12.97K NEW
Renaissance Technologies 49.7K +4.5K +10.0%
NA National Bank of Canada 196 -151 -43.5%
MS Morgan Stanley 17 +17 NEW
Proequities 0 0

Financial report summary

?
Competition
CNBX Pharmaceuticals

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg